Uromems raised €16M in a Series B round in May 2020. The company is based in Grenoble, France. Investors in the round: Arbevel, Hil-Invest. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €16M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
